3WHO.What is DOTS strategy[M].Geneva:WHO/CDC/TB,1999.270.
4Zang LX,Tu DH,Enarson DA.The impact of directly-observedtreatment on the epidemiology of tuberculosis in Beijing[J].Int J Tuberc Lung Dis,2000,4(10):904-910.
5Cao JP,Zhang LY,Zhu JQ,et al.Two-year follow up of directly observed intermittent regimens for smear positive pulmonary tuberculosis in China[J].Int J Tuberc Lung Dis,1998,2(5):360-364.
6Wilkinson D,Anderson E,Davies GR,et al.Efficacy of twice weekly treatment for tuberculosis given under direct observation in Africa[J].Trans R Soc Trop Med Hyg,1997,91(1):87-89.
7Hussain Z, Kar P, Husain SA. Antituberculosis drug-induced hepatitis: risk factors, prevention and management. Indian J Exp Biol,2003,41 : 1226-1232.
8Onnerod LP, Horsfleld N. Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tuber Lung Dis, 1996,77:37-42.
9Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology, 1997,26,664-669.
10Danan G, Benichou C, Flahault A. Score of suspected drug-induced acute liver disorders. Presentation of an evaluation sheet. Gastroenterol Clin Biol, 1993,17 ( 5 pt 2 ) : H22-H24.
